drugset / Trial / NCT03272711

Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training

NCT03272711 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this research study is to examine the potential benefits of vortioxetine in combination with at-home computerized cognitive training program to improve cognition, such as memory, attention, and concentration. This study will compare the effectiveness of vortioxetine plus cognitive training versus placebo plus cognitive training.

Timeline

Start
2016-08-31
Primary completion
2019-01-24
Completion
2019-01-24

Outcome

Met primary endpoint

paper Participants who received vortioxetine with cognitive training showed a greater increase in global cognitive performance compared with those who received placebo with cognitive training. PMID 32212856 ↗

paper This separation was significant at week 12 but not at other assessment time points. PMID 32212856 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Vortioxetine Unknown 10 mg —